Media Database
>
Rebecca Robbins

Rebecca Robbins

Pharmaceutical Reporter at The New York Times

Contact this person
Email address
r*****@*******.comGet email address
Influence score
60
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

nytimes.com

This Closed Factory Shows How Hard Reviving Drug Manufacturing Will Be

President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines.
nytimes.com

Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb ...

In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.
nytimes.com

Kimberly-Clark Agrees to Buy Kenvue, Maker of Tylenol, for $40 Billion

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a common pain reliever is linked to autism.
nytimes.com

F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs

The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs.
nytimes.com

Texas Sues Tylenol Makers, Claiming They Hid Autism Risks

The lawsuit follows claims by President Trump that linked use by pregnant women of acetaminophen to autism, a connection that is unproven.
nytimes.com

America Is Heavily Reliant on China for Raw Materials in Medicines

A new analysis found that nearly 700 drugs approved for use in the United States depend on chemicals solely produced in China.
nytimes.com

Trump Announces a Deal on Drug Prices With AstraZeneca

The president and top health officials acknowledged using the leverage of tariff threats to forge an agreement. Other companies are still in negotiations with the White House.
nytimes.com

Taking Too Much Tylenol Has Proven Risks. Trump Didn’t Talk About T...

Acetaminophen’s link to autism is unproven. But hundreds of Americans accidentally overdose on the drug each year, suffering liver damage that can require a transplant or even be fatal.
nytimes.com

How Trump’s Online Drugstore May Affect Your Drug Costs

President Trump and top health officials announced a deal with Pfizer to try to lower Medicaid prices, and a website to help consumers buy drugs directly from manufacturers.
nytimes.com

Trump Announces Deal With Pfizer to Sell Drugs to Medicaid at Europ...

The administration also announced it will create a website, TrumpRx, that will help consumers buy drugs directly from manufacturers.
nytimes.com

Where Your Medicines Are Made

President Trump’s planned pharmaceutical tariffs threaten to hit many of the most common and well-known drugs that Americans take.
nytimes.com

How Trump’s Latest Tariffs May Affect Your Medicines

The president said he would impose a tariff of 100 percent on certain brand-name drugs. Here’s what we know so far.
nytimes.com

Trump May Try to Force Drugmakers to Match European Prices

A federal website notice, deleted and then reposted by the administration, provides a hint that more aggressive pricing policies may be coming.
nytimes.com

La empresa detrás de Tylenol intenta sortear su crisis más reciente

Kenvue, una empresa derivada de Johnson & Johnson, se enfrenta a una pesadilla de relaciones públicas ya que el presidente Trump y otros sugieren vínculos no probados entre el analgésico y el autismo.
nytimes.com

Harvard Dean Was Paid $150,000 as an Expert Witness in Tylenol Laws...

The Trump administration has cited Dr. Andrea Baccarelli’s expertise to warn against using acetaminophen — the active ingredient in Tylenol — in pregnancy, based on an unproven autism link.
nytimes.com

Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Cr...

Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever and autism.
nytimes.com

A New Shot for Cancer Is Convenient, but Poised to Keep Prices High

The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and increase costs by billions of dollars.
nytimes.com

U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on ...

Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions over proposed anti-China measures.
nytimes.com

Trump Moves to Crack Down on Drug Advertising

The administration is proposing a return to a 1990s-era policy that kept most drug ads off TV. That could dent the revenues of drugmakers and major networks.
nytimes.com

Book Review: ‘Everything Is Tuberculosis,’ by John Green

In a new nonfiction book, the Y.A. novelist describes the disease as a window into “the folly and brilliance and cruelty and compassion of humans.”
nytimes.com

Tariffs Set to Hit Ireland, Where U.S. Drugmakers Play Tax Games

Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a world without President Trump’s tariffs.